Sponsor Pipeline

Kali Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
1
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT07564154
A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA)		 Recruitment opened
Active Trials by Phase
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07234773 A First-in-human Study of KT501 Administered Subcutaneously to Patients With Rheumatoid… Rheumatoid Arthritis (RA) Recruiting
NCT07564154 A First-in-human Study of KT502 in Adult Participants With Rheumatoid Arthritis (RA) Rheumatoid Arthritis (RA) Recruiting
Disease Areas
Rheumatoid Arthritis (2)
Get alerts when Kali Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free